CO122 Late-Onset Pompe Disease (LOPD) Patients Treated with Avalglucosidase Alfa Show Favorable Results Compared to Cipaglucosidase Alfa Plus Miglustat: Indirect Treatment Comparison
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.195
https://www.valueinhealthjournal.com/article/S1098-3015(23)00295-4/fulltext
Title :
CO122 Late-Onset Pompe Disease (LOPD) Patients Treated with Avalglucosidase Alfa Show Favorable Results Compared to Cipaglucosidase Alfa Plus Miglustat: Indirect Treatment Comparison
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00295-4&doi=10.1016/j.jval.2023.03.195
First page :
Section Title :
Open access? :
No
Section Order :
11396